|Articles|May 1, 2002
- Applied Clinical Trials-05-01-2002
Brian Koziol
Family man, educator, mentor, athlete--and a man on a quest with Amgen Inc for new and better oncology treatments.
Advertisement
Articles in this issue
over 24 years ago
Letters to the Editorover 24 years ago
Parents for Orphansover 24 years ago
Fraud, Abuse, and Consentover 24 years ago
Identifying and Documenting Adverse Events at Clinical Study Sitesover 24 years ago
A Model-Based Method for Improving Protocol QualityAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
2
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5